Cholesterol differentially modulates the activity of opioid and muscarinic receptors via a common binding site
Authors:
Open Access
- 29 August 2025
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 242 (Pt 1) , 117296
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Akademie Věd České Republiky (67985823)
- Ministry of Education Youth and Sports of the Czech Republic (LX22NPO5107)
- European Commission
This publication has 69 references indexed in Scilit:
- Cholesterol interaction motifs in G protein‐coupled receptors: Slippery hot spots?WIREs Mechanisms of Disease, 2020
- Challenges and approaches to understand cholesterol-binding impact on membrane protein function: an NMR viewCellular and Molecular Life Sciences, 2018
- CHARMM-GUIMembrane Buildertoward realistic biological membrane simulationsJournal of Computational Chemistry, 2014
- Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichmentsJournal of Computer-Aided Molecular Design, 2013
- Overview of Muscarinic Receptor Subtypes2011
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- CHARMM‐GUI: A web‐based graphical user interface for CHARMMJournal of Computational Chemistry, 2008
- A fast, scalable method for the parallel evaluation of distance‐limited pairwise particle interactionsJournal of Computational Chemistry, 2005
- The effects of the neurosteroids: pregnenolone, progesterone and dehydroepiandrosterone on muscarinic receptor-induced responses in Xenopus oocytes expressing M1 and M3 receptorsNaunyn-Schmiedeberg's Archives of Pharmacology, 2005
- Increasing the precision of comparative models with YASARA NOVA—a self‐parameterizing force fieldProteins: Structure, Function, and Bioinformatics, 2002